Epidermal Growth Factor Receptor (EGFR) inhibitors are a class of targeted cancer therapies designed to block the activity of the EGFR, a protein that, when mutated or overexpressed, can promote the growth of cancer cells. These inhibitors are used to treat various cancers, including non-small cell lung cancer and colorectal cancer, by interfering with the signaling pathways that drive tumor growth and survival.